Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49.6M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
7.45M
-
Shares change
-
-789K
-
Total reported value, excl. options
-
$9.9M
-
Value change
-
-$1.04M
-
Put/Call ratio
-
0
-
Number of buys
-
25
-
Number of sells
-
-19
-
Price
-
$1.33
Significant Holders of PDS Biotechnology Corp - Common (PDSB) as of Q2 2025
65 filings reported holding PDSB - PDS Biotechnology Corp - Common as of Q2 2025.
PDS Biotechnology Corp - Common (PDSB) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.45M shares
of 49.6M outstanding shares and own 15.02% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (2.24M shares), VANGUARD GROUP INC (1.95M shares), UBS Group AG (543K shares), BlackRock, Inc. (514K shares), GEODE CAPITAL MANAGEMENT, LLC (418K shares), BLAIR WILLIAM & CO/IL (250K shares), CITADEL ADVISORS LLC (249K shares), STATE STREET CORP (133K shares), NORTHERN TRUST CORP (122K shares), and RENAISSANCE TECHNOLOGIES LLC (106K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.